Search

Marcia Stephens Noble

Examiner (ID: 19297, Phone: (571)272-5545 , Office: P/1632 )

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
1089
Issued Applications
595
Pending Applications
110
Abandoned Applications
393

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14072113 [patent_doc_number] => 20190084944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-21 [patent_title] => COMPOUNDS FOR INDUCING PROLIFERATION AND DIFFERENTIATION OF CELLS, AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/135468 [patent_app_country] => US [patent_app_date] => 2018-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16135468 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/135468
Compounds for inducing proliferation and differentiation of cells, and methods of use thereof Sep 18, 2018 Issued
Array ( [id] => 17220177 [patent_doc_number] => 11172657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-16 [patent_title] => Method for developing organ that lacks specific functional cell [patent_app_type] => utility [patent_app_number] => 16/638440 [patent_app_country] => US [patent_app_date] => 2018-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 5285 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16638440 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/638440
Method for developing organ that lacks specific functional cell Sep 17, 2018 Issued
Array ( [id] => 19274611 [patent_doc_number] => 12024722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Methods for reprogramming cells and uses thereof [patent_app_type] => utility [patent_app_number] => 16/125528 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67893 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125528 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/125528
Methods for reprogramming cells and uses thereof Sep 6, 2018 Issued
Array ( [id] => 16414518 [patent_doc_number] => 10822394 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => Method of producing recombinant high molecular weight vWF in cell culture [patent_app_type] => utility [patent_app_number] => 16/125141 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 20 [patent_no_of_words] => 41872 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16125141 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/125141
Method of producing recombinant high molecular weight vWF in cell culture Sep 6, 2018 Issued
Array ( [id] => 13987155 [patent_doc_number] => 20190062735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => CRISPR-CPF1-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 16/121152 [patent_app_country] => US [patent_app_date] => 2018-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32709 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16121152 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/121152
Crispr-CPF1-related methods, compositions and components for cancer immunotherapy Sep 3, 2018 Issued
Array ( [id] => 13986467 [patent_doc_number] => 20190062391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY [patent_app_type] => utility [patent_app_number] => 16/118488 [patent_app_country] => US [patent_app_date] => 2018-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118488 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/118488
USE OF VEGF-B FOR TREATING DISEASES INDUCED BY OXIDATIVE INJURY Aug 30, 2018 Abandoned
Array ( [id] => 13982493 [patent_doc_number] => 20190060404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => USE OF VEGF-B FOR TREATING DISEASES INVOLVING NEOANGIOGENESIS [patent_app_type] => utility [patent_app_number] => 16/118486 [patent_app_country] => US [patent_app_date] => 2018-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8051 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16118486 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/118486
USE OF VEGF-B FOR TREATING DISEASES INVOLVING NEOANGIOGENESIS Aug 30, 2018 Abandoned
Array ( [id] => 13987081 [patent_doc_number] => 20190062698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-28 [patent_title] => DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS [patent_app_type] => utility [patent_app_number] => 16/113839 [patent_app_country] => US [patent_app_date] => 2018-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19111 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113839 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/113839
DERIVATION OF EMBRYONIC STEM CELLS AND EMBRYO-DERIVED CELLS Aug 26, 2018 Abandoned
Array ( [id] => 13958353 [patent_doc_number] => 20190055520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-21 [patent_title] => METHOD OF DIFFERENTIATING HUMAN PLURIPOTENT STEM CELLS TO PODOCYTES [patent_app_type] => utility [patent_app_number] => 16/105397 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13360 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16105397 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/105397
Method of differentiating human pluripotent stem cells to podocytes Aug 19, 2018 Issued
Array ( [id] => 14625139 [patent_doc_number] => 20190225937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK [patent_app_type] => utility [patent_app_number] => 16/102640 [patent_app_country] => US [patent_app_date] => 2018-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15858 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -38 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16102640 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/102640
BANK OF STEM CELLS FOR PRODUCING CELLS FOR TRANSPLANTATION HAVING HLA ANTIGENS MATCHING THOSE OF TRANSPLANT RECIPIENTS AND METHODS FOR MAKING AND USING SUCH A STEM CELL BANK Aug 12, 2018 Abandoned
Array ( [id] => 16506424 [patent_doc_number] => 20200385680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-10 [patent_title] => IMMORTALIZED SWEAT GLAND MYOEPITHELIAL CELL [patent_app_type] => utility [patent_app_number] => 16/626052 [patent_app_country] => US [patent_app_date] => 2018-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14810 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626052 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/626052
Immortalized sweat gland myoepithelial cell Aug 6, 2018 Issued
Array ( [id] => 17587890 [patent_doc_number] => 11326148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-10 [patent_title] => Methods of differentiating stem cell-derived ectodermal lineage precursors [patent_app_type] => utility [patent_app_number] => 16/054071 [patent_app_country] => US [patent_app_date] => 2018-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 117 [patent_no_of_words] => 30682 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054071 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/054071
Methods of differentiating stem cell-derived ectodermal lineage precursors Aug 2, 2018 Issued
Array ( [id] => 13871491 [patent_doc_number] => 20190032086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-31 [patent_title] => METHOD FOR PREPARING A GENE KNOCK-OUT CANINE WITH SOMATIC CELL CLONING TECHNOLOGY [patent_app_type] => utility [patent_app_number] => 16/045683 [patent_app_country] => US [patent_app_date] => 2018-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6500 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045683 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/045683
METHOD FOR PREPARING A GENE KNOCK-OUT CANINE WITH SOMATIC CELL CLONING TECHNOLOGY Jul 24, 2018 Abandoned
Array ( [id] => 14360623 [patent_doc_number] => 10301599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-28 [patent_title] => Methods and products for transfection [patent_app_type] => utility [patent_app_number] => 16/037597 [patent_app_country] => US [patent_app_date] => 2018-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 18713 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16037597 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/037597
Methods and products for transfection Jul 16, 2018 Issued
Array ( [id] => 15055253 [patent_doc_number] => 10457917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Methods for reprogramming somatic cells [patent_app_type] => utility [patent_app_number] => 16/030815 [patent_app_country] => US [patent_app_date] => 2018-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10831 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030815 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/030815
Methods for reprogramming somatic cells Jul 8, 2018 Issued
Array ( [id] => 13826561 [patent_doc_number] => 20190016765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS [patent_app_type] => utility [patent_app_number] => 16/014124 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8714 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014124 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/014124
ENDOPLASMIC RETICULUM LOCALIZATION SIGNALS Jun 20, 2018 Abandoned
Array ( [id] => 13493567 [patent_doc_number] => 20180298326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/014765 [patent_app_country] => US [patent_app_date] => 2018-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33560 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014765 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/014765
METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF Jun 20, 2018 Abandoned
Array ( [id] => 16756817 [patent_doc_number] => 10975357 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-04-13 [patent_title] => Methods and compositions related to differentiated lung cells [patent_app_type] => utility [patent_app_number] => 16/011809 [patent_app_country] => US [patent_app_date] => 2018-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 69 [patent_no_of_words] => 40924 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16011809 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/011809
Methods and compositions related to differentiated lung cells Jun 18, 2018 Issued
Array ( [id] => 13778759 [patent_doc_number] => 20190002918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => DONOR PLASMID VECTORS [patent_app_type] => utility [patent_app_number] => 16/012686 [patent_app_country] => US [patent_app_date] => 2018-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8623 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16012686 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/012686
Donor plasmid vectors Jun 18, 2018 Issued
Array ( [id] => 13573861 [patent_doc_number] => 20180338479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => TRANSGENIC ANIMAL FOR PRODUCTION OF ANTIBODIES HAVING MINIMAL CDRS [patent_app_type] => utility [patent_app_number] => 15/996373 [patent_app_country] => US [patent_app_date] => 2018-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15996373 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/996373
Transgenic animal for production of antibodies having minimal CDRS May 31, 2018 Issued
Menu